Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system
Clinical Science · 15.07.2026 · 140 (7) · 1473-1496
DOI: 10.1042/cs20250039 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 24.06.2026. Verfasst von John E Hall und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, U.S.A. Hauptthemen laut MEDLINE: Leptin, Brain, Receptor, Melanocortin, Type 4, Adipocytes. Die Arbeit nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), American Heart Association (AHA).
Abstract (Originalsprache)
Tonic activation of central nervous system (CNS) leptin receptors (LepRs) and melanocortin 4 receptors (MC4Rs) is critical for maintaining normal cardiometabolic function. Deficiency of CNS LepR or MC4R signaling causes severe obesity and is accompanied by multiple metabolic abnormalities including insulin resistance, glucose intolerance, and hyperlipidemia that are only partially explained by obesity. Defective LepR and MC4R signaling also causes dysfunction of the sympathetic nervous system (SNS) and blood pressure (BP) regulation. Hyperleptinemia and activation of the CNS melanocortin system in obesity are important compensatory mechanisms that attenuate abnormalities of glucose and lipid metabolism but may also contribute to SNS activation and increased BP. Despite potentially adverse effects of increases in SNS activity and BP, pharmacological activation of brain LepRs and MC4Rs may provide an important therapeutic approach for protecting target organs, such as the heart, kidneys, and brain, from ischemic injury by improving mitochondrial function and ATP production. However, additional preclinical studies are needed to address mechanistic questions before clinical studies are begun to test the effectiveness of leptin and MC4R agonists for treating people with ischemic injury of target organs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, U.S.A.
- Mississippi Center for Obesity Research, University of Mississippi Medical Center, Jackson, MS, U.S.A.
- Cardiorenal and Metabolic Diseases Research Center, University of Mississippi Medical Center, Jackson, MS, U.S.A.
- Mississippi Center for Clinical and Translational Research, University of Mississippi Medical Center, Jackson, MS, U.S.A.
- Department of Medicine, University of Mississippi Medical Center, Jackson, MS, U.S.A.
ORCID-Profile: John E Hall, Ana C M Omoto, Jussara M do Carmo, Alexandre A da Silva, Alan J Mouton, Zhen Wang, Michael E Hall
Förderung
- NHLBI NIH HHS
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- American Heart Association (AHA)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIGMS NIH HHS
Zitieren
APA
Hall, J. E., Omoto, A. C. M., do Carmo, J. M., da Silva, A. A., Mouton, A. J., Wang, Z., & Hall, M. E. (2026). Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system. Clinical Science, 140(7), 1473-1496. https://doi.org/10.1042/cs20250039
Vancouver
Hall JE, Omoto ACM, do Carmo JM, da Silva AA, Mouton AJ, Wang Z, et al. Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system. Clinical Science. 2026;140(7):1473-1496. doi:10.1042/cs20250039
BibTeX
@article{Hall2026,
author = {Hall, John E and Omoto, Ana C M and do Carmo, Jussara M and da Silva, Alexandre A and Mouton, Alan J and Wang, Zhen and Hall, Michael E},
title = {Cardiometabolic regulation by adipocyte-derived leptin and the brain melanocortin system},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {7},
pages = {1473--1496},
doi = {10.1042/cs20250039}
}
EUVIMED